Thomas P. Loughran Jr.
American physician
Thomas P. Loughran Jr.'s AcademicInfluence.com Rankings
Download Badge
Philosophy
Thomas P. Loughran Jr.'s Degrees
- PhD Biomedical Engineering Johns Hopkins University
Why Is Thomas P. Loughran Jr. Influential?
(Suggest an Edit or Addition)According to Wikipedia, Thomas P. Loughran, Jr. is an American physician-scientist who specializes in cancer research and treatment. He became director of the University of Virginia Cancer Center, F. Palmer Weber-Smithfield Foods Professor of Oncology Research and Professor of Medicine at the University of Virginia on August 15, 2013. Between 2003 and 2013, Loughran served as the founding director of the Penn State Hershey Cancer Institute and professor of medicine at the Penn State College of Medicine. His previous appointments included program leader of hematologic malignancies at the H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida, associate director of the Bone Marrow Transplant Program at SUNY Health Science Center and chief of hematology at the Syracuse Veteran's Affairs Medical Center in Syracuse, New York. Loughran completed his fellowship in medical oncology in 1985 at the Fred Hutchinson Cancer Research Center in Seattle, Washington under direction of Nobel Laureate E. Donnall Thomas. He remained on faculty there for seven years. Loughran earned his medical degree from Hahnemann Medical School in Philadelphia in 1979.
Thomas P. Loughran Jr.'s Published Works
Published Works
- Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia (1998) (64)
- Large granular lymphocyte leukaemia occurring after renal transplantation (1998) (58)
- Splenic Extramedullary Hematopoiesis in a Patient Receiving Intermittently Administered Granulocyte ColonyStimulating Factor (1993) (45)
- C6-Ceramide Nanoliposomes Target the Warburg Effect in Chronic Lymphocytic Leukemia (2013) (39)
- Clinicopathological features of aggressive large granular lymphocyte leukaemia resemble Fas ligand transgenic mice (2000) (35)
- Maritoclax induces apoptosis in acute myeloid leukemia cells with elevated Mcl-1 expression (2014) (29)
- Suppression of farnesyltransferase activity in acute myeloid leukemia and myelodysplastic syndrome: current understanding and recommended use of tipifarnib (2010) (24)
- Spontaneous resolution of p58/EB6 antigen restricted NK‐type lymphoproliferative disease of granular lymphocytes: role of Epstein Barr virus infection (1997) (16)
- Extramedullary granulopoiesis mimicking recurrent lymphoma after prolonged administration of human recombinant granulocyte colony-stimulating factor (1998) (10)
- Estimation of Daily Proteinuria in Patients with Multiple Myeloma by Using the Protein-to-Creatinine Ratio in Random Urine Samples (2010) (6)
- miR-181a is a novel player in the STAT3-mediated survival network of TCRαβ+ CD8+ T large granular lymphocyte leukemia (2021) (4)
- Faculty Opinions recommendation of Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia. (2020) (0)
This paper list is powered by the following services:
Other Resources About Thomas P. Loughran Jr.
What Schools Are Affiliated With Thomas P. Loughran Jr.?
Thomas P. Loughran Jr. is affiliated with the following schools: